These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 36852491

  • 1. Age differences of patients treated with wearable cardioverter defibrillator: Data from a multicentre registry.
    El-Battrawy I, Tenbrink D, Kovacs B, Dreher TC, Blockhaus C, Klein N, Shin DI, Hijazi M, Rosenkaimer S, Beiert T, Abumayyaleh M, Saguner AM, Kowitz J, Erath JW, Duru F, Mügge A, Aweimer A, Akin I.
    Eur J Clin Invest; 2023 Jul; 53(7):e13977. PubMed ID: 36852491
    [Abstract] [Full Text] [Related]

  • 2. Experience with the wearable cardioverter-defibrillator in older patients: Results from the Prospective Registry of Patients Using the Wearable Cardioverter-Defibrillator.
    Daimee UA, Vermilye K, Moss AJ, Goldenberg I, Klein HU, McNitt S, Zareba W, Kutyifa V.
    Heart Rhythm; 2018 Sep; 15(9):1379-1386. PubMed ID: 29678779
    [Abstract] [Full Text] [Related]

  • 3. Real life experience with the wearable cardioverter-defibrillator in an international multicenter Registry.
    El-Battrawy I, Kovacs B, Dreher TC, Klein N, Rosenkaimer S, Röger S, Kuschyk J, Saguner AM, Kowitz J, Erath JW, Duru F, Akin I.
    Sci Rep; 2022 Feb 25; 12(1):3203. PubMed ID: 35217697
    [Abstract] [Full Text] [Related]

  • 4. Sex differences in arrhythmic burden with the wearable cardioverter-defibrillator.
    Goldenberg I, Erath JW, Russo AM, Burch AE, Assmus B, Bonderman D, McNitt S, Kutyifa V.
    Heart Rhythm; 2021 Mar 25; 18(3):404-410. PubMed ID: 33248269
    [Abstract] [Full Text] [Related]

  • 5. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
    Kutyifa V, Moss AJ, Klein H, Biton Y, McNitt S, MacKecknie B, Zareba W, Goldenberg I.
    Circulation; 2015 Oct 27; 132(17):1613-9. PubMed ID: 26316618
    [Abstract] [Full Text] [Related]

  • 6. Outcomes during and after the use of the wearable cardioverter-defibrillator in a tertiary-care and a regional hospital in Switzerland.
    Kovacs B, Reek S, Saguner AM, Krasniqi N, Eriksson U, Duru F.
    Swiss Med Wkly; 2019 Nov 04; 149():w20136. PubMed ID: 31707723
    [Abstract] [Full Text] [Related]

  • 7. Use of the wearable cardioverter-defibrillator - the Swiss experience.
    Kovacs B, Reek S, Sticherling C, Schaer B, Linka A, Ammann P, Brenner R, Krasniqi N, Müller AS, Dzemali O, Kobza R, Grebmer C, Haegeli L, Berg J, Mayer K, Schläpfer J, Domenichini G, Reichlin T, Roten L, Burri H, Eriksson U, Saguner AM, Steffel J, Duru F, Swiss Wcd Registry.
    Swiss Med Wkly; 2020 Sep 21; 150():w20343. PubMed ID: 33035354
    [Abstract] [Full Text] [Related]

  • 8. Wearable cardioverter defibrillator after cardiac surgery: Analysis of real-life data from patients at transient risk of sudden cardiac death.
    Elbayomi M, Weyand M, Seitz T, Harig F.
    Ann Noninvasive Electrocardiol; 2023 Mar 21; 28(2):e13048. PubMed ID: 36723848
    [Abstract] [Full Text] [Related]

  • 9. Extended use of the wearable cardioverter-defibrillator in patients at risk for sudden cardiac death.
    Kutyifa V, Vermilye K, Daimee UA, McNitt S, Klein H, Moss AJ.
    Europace; 2018 Sep 01; 20(FI2):f225-f232. PubMed ID: 29905788
    [Abstract] [Full Text] [Related]

  • 10. Sex differences and adherence of patients treated with wearable cardioverter-defibrillator: Insights from an international multicenter register.
    Abumayyaleh M, Dreher TC, Rosenkaimer S, Röger S, Erath JW, Klein N, Kovacs B, Duru F, Saguner AM, El-Battrawy I, Akin I.
    J Cardiovasc Electrophysiol; 2022 Nov 01; 33(11):2243-2249. PubMed ID: 35930623
    [Abstract] [Full Text] [Related]

  • 11. Wearable cardioverter-defibrillator in patients with a transient risk of sudden cardiac death: the WEARIT-France cohort study.
    Garcia R, Combes N, Defaye P, Narayanan K, Guedon-Moreau L, Boveda S, Blangy H, Bouet J, Briand F, Chevalier P, Cottin Y, Da Costa A, Degand B, Deharo JC, Eschalier R, Extramiana F, Goralski M, Guy-Moyat B, Guyomar Y, Hermida JS, Jourda F, Lellouche N, Mahfoud M, Manenti V, Mansourati J, Martin A, Pasquié JL, Ritter P, Rollin A, Tibi T, Yalioua A, Gras D, Sadoul N, Piot O, Leclercq C, Marijon E.
    Europace; 2021 Jan 27; 23(1):73-81. PubMed ID: 33257972
    [Abstract] [Full Text] [Related]

  • 12. The impact of wearable cardioverter-defibrillator use on long-term decision for implantation of a cardioverter-defibrillator in a semirural acute care hospital.
    Sinha AM, Bense J, Hohenforst-Schmidt W.
    J Interv Card Electrophysiol; 2021 Nov 27; 62(2):401-407. PubMed ID: 33200285
    [Abstract] [Full Text] [Related]

  • 13. The US Experience of the Wearable Cardioverter-Defibrillator in Pediatric Patients.
    Spar DS, Bianco NR, Knilans TK, Czosek RJ, Anderson JB.
    Circ Arrhythm Electrophysiol; 2018 Jul 27; 11(7):e006163. PubMed ID: 29945928
    [Abstract] [Full Text] [Related]

  • 14. Use of the Wearable Cardioverter-Defibrillator Among Patients With Myocarditis and Reduced Ejection Fraction or Ventricular Tachyarrhythmia: Data From a Multicenter Registry.
    El-Battrawy I, Koepsel K, Tenbrink D, Kovacs B, Dreher TC, Blockhaus C, Gotzmann M, Klein N, Kuntz T, Shin DI, Lapp H, Rosenkaimer S, Abumayyaleh M, Hamdani N, Saguner AM, Kowitz J, Erath JW, Duru F, Mügge A, Akin I, Aweimer A, Beiert T.
    J Am Heart Assoc; 2023 Sep 19; 12(18):e030615. PubMed ID: 37681569
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the Outcome of Patients Protected by the Wearable Cardioverter Defibrillator (WCD) for <90 Wear Days versus ≥90 Wear Days.
    Dreher TC, El-Battrawy I, RÖger S, Rosenkaimer SL, Gerhards S, Kuschyk J, Borggrefe M, Akin I.
    In Vivo; 2020 Sep 19; 34(6):3601-3610. PubMed ID: 33144474
    [Abstract] [Full Text] [Related]

  • 16. A Patch Wearable Cardioverter-Defibrillator for Patients at Risk of Sudden Cardiac Arrest.
    Hummel J, Houmsse M, Tomassoni G, Nair D, Romero J, Hargrove J, Mathews K, Thakkar AB, Ullery S, Eapen ZJ, Kumar UN, Mehran R, Butler J, Jewel IDE Study Investigators.
    J Am Coll Cardiol; 2024 Aug 06; 84(6):525-536. PubMed ID: 39084827
    [Abstract] [Full Text] [Related]

  • 17. Wearable cardioverter defibrillator multicentre experience in a large cardiac surgery cohort at transient risk of sudden cardiac death.
    Kuehn C, Ruemke S, Rellecke P, Lichtenberg A, Joskowiak D, Hagl C, Hassan M, Leyh RG, Erler S, Garbade J, Eifert S, Grieshaber P, Boening A, Doenst T, Velichkov I, Madej T, Knaut M, Hain A, Burger H.
    Eur J Cardiothorac Surg; 2022 May 02; 61(5):1031-1040. PubMed ID: 35174386
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study.
    Duncker D, König T, Hohmann S, Bauersachs J, Veltmann C.
    J Am Heart Assoc; 2017 Jan 17; 6(1):. PubMed ID: 28096098
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.